Organization Overview
Alternative names
abemaciclib (verzenio) (1 trial)
aldesleukin (proleukin) (3 trials)
allogeneic cord blood (1 trial)
alloreactive nk cells (1 trial)
autologous natural killer cells (1 trial)
cyclophosphamide (cytoxan) (4 trials)
dabrafenib (tafinlar) (1 trial)
fludarabine (fludara) (4 trials)
Blast Crisis (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Renal Cell (Phase 1)
Graft vs Host Disease (Phase 2)
Hematologic Diseases (Phase 1)
Leukemia (Phase 2)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Accelerated Phase (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Melanoma (Phase 2)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Papilloma (Phase 4)
Preleukemia (Phase 2)
Skin Neoplasms (Phase 1)
Syndrome (Phase 2)